COMMUNIQUÉS West-GlobeNewswire

Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference
09/01/2026
MALVERN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri [...]
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
09/01/2026
Press release – No. 2 / 2026 Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to Gefion, Denmark’s flagship AI [...]
Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials
09/01/2026
Wallonia Minister of Economy and Employment Pierre-Yves Jeholet will perform opening ceremony on 9 January 2026 New cleanroom facility allows production of one million doses per year Ramping up for clinical development [...]
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
09/01/2026
Data from the first in human study on O3R-5671’s potent TNFα inhibition to be presented Dosing of the final cohort in the first in human study has been initiated Studies in ulcerative colitis and psoriasis to initiate [...]
Now Available: 1G Live Resin THCA Disposable By The Hemp Doctor
09/01/2026
MOORESVILLE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Trusted by customers for high-quality hemp-derived THC products and vapes since 2018, The Hemp Doctor launches its newest innovation: the ZOOTED | THCA Live Resin 1G [...]
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
09/01/2026
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc . (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today [...]
Tecan reports return to sales growth and strong order entry in the second half of 2025
09/01/2026
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports return to sales growth and strong order entry in the second half of 2025 Group sales of CHF 882.5 million, down 1.6% [...]
Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
09/01/2026
Saint Herblain (France), le 9 janvier 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante rencontreront les [...]
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
09/01/2026
Saint Herblain (France), January 09, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that members of its management team will meet one-on-one with existing [...]
ReadyRx Sermorelin: Prescription Telehealth Access in Injectable and ODT Formats — 2026 Platform Analysis of Compounding Standards and Provider Structure
09/01/2026
Market Analysis: How Three-Entity Telehealth Platforms Handle Prescription Peptide Evaluation, Compounded Medication Dispensing, and Realistic Timeline Variability AUSTIN, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: [...]
True Keto Fusion Keto+ ACV Gummies: What Consumers Should Know as BHB-ACV Category Expands Into 2026
09/01/2026
An Informational Analysis of True Keto Fusion Gummies, BHB Ketone Salts, Apple Cider Vinegar Gummy Supplements, and Consumer Evaluation Criteria for the Keto ACV Gummies Category in 2026 Chicago, IL, Jan. 08, 2026 ( [...]
"Best Skin Tag Remover" Consumer Search Analysis: Topical Solutions vs Freezing Kits vs Clinical Procedures – NutriDerma Guard Format Overview
09/01/2026
January 2026 Consumer Report: At-Home Skin Tag Removal Format Comparison, Natural Ingredient Profile Context, and Product Selection Considerations for Topical vs Professional Methods Largo, FL, Jan. 08, 2026 (GLOBE [...]
"Best Peptides for Hair Growth" Search Trends Surge as Telehealth Platforms Expand FDA-Approved Medication Access in 2026
09/01/2026
January 2026 Consumer Report Examines How PeterMD and Similar Platforms Facilitate Prescription Hair Loss Treatment Access Through Licensed Telehealth Evaluation Vero Beach, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- [...]
AquaFit Weight Loss Supplement Investigation: 2026 Thermogenic Research Examines Green Tea, Berberine, and Metabolic Support Ingredients
09/01/2026
Alpha Lipoic Acid, Chromium, Cayenne, and Korean Ginseng Capsule Analysis Amid January 2026 Natural Weight Loss Supplement Search Trends AURORA, COLORADO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is [...]
Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)
08/01/2026
– Once-weekly TransCon ® CNP and TransCon ® hGH combination therapy showed durable growth without compromising safety or tolerability at 52 weeks – Annualized growth velocity (AGV) exceeded the 97th-percentile of [...]
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
08/01/2026
-- Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX [...]
Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis
08/01/2026
Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespective of modulator- [...]
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026
08/01/2026
SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart or “the Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its [...]
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System
08/01/2026
twiist™ becomes the first AID system compatible with Senseonics Eversense® 365 one-year CGM GERMANTOWN, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company [...]

Pages